Alastin Skincare Appoints Amber Edwards as CCO

Edwards has previously held leadership roles at Sinclair Pharma and Allergan. Photo credit: Alastin (Photo credit: Alastin)

Alastin Skincare has tapped pharmaceutical industry veteran Amber Edwards to be its new chief commercial officer. Edwards began her career in sales and marketing roles at pharmaceutical giant Pfizer and went on to serve as Allergan’s vice president of international strategic marketing of its medical aesthetics franchise in the UK. She also worked with Allergan in the U.S. in aesthetic and therapeutic areas and most recently was the president of North America at Sinclair Pharma. In her new role, Edwards will help lead Alastin’s commercialization activities both within the U.S. and abroad. “I am thrilled to join an organization that has made such a notable mark in a crowded segment, and at a time they are experiencing tremendous opportunity and momentum,” says Edwards. “Alastin has demonstrated a commitment to science and ultimately to patients, identifying an innovative approach to helping physicians maximize patient results. I believe they have only scratched the surface and am honored to lead the commercial path forward."


What's New in Med Spa Products

4 Out Of 5 People Won't Visit Med Spas Without Safety Standards

Alastin Skincare Announces Issuance of Fourth U.S. Patent Incorporating TriHex Technology